TheraSourceLLC Logo
Discovering novel therapeutics for inflammatory diseases
  • Home
  • About Us
  • Technologies
    • rhMFG-E8
      • Acute Kidney Injury
      • Hemorrhagic Shock
      • Inflammatory Bowel Disease
    • Ghrelin
      • Acute Ischemic Stroke
      • Acute Radiation Syndrome
    • Ghrelin plus Growth Hormone
      • Sepsis
  • Partnership
  • In the News
  • Contact Us
  • Menu

Partnership

Posted on September 30, 2014January 12, 2016 by Howard

TheraSource seeks strategic VC funding and pharma partners to co-develop and commercialize its technologies in various clinical indications. TheraSource also welcomes the opportunity to license its technologies.

rhMFG-E8 for Acute Kidney Injury - Executive Summary

 
Return To Top
  • Company Overview
  • Technologies
  • Partnership
  • In the News
  • Contact Us

350 Community Drive · Manhasset · NY 11030 · United States 516.562.1370 Info@therasourcellc.com
Copyright © 2016 TheraSource, LLC